|
Industry: Generics
|
|
|
| This report provides information on the therapeutic development for Brain Hemorrhage, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Brain |
|
|
| The report is an essential source of information and analysis on the KALYDECO (ivacaftor, VX-770) for the treatment of Cystic Fibrosis (CF) patients with G551D mutation. The report provides insights on the product clinical information and how it will brin |
|
|
| GBI Research, the leading business intelligence provider has released its latest research |
|
|
| Global Markets Direct\'s, \'Adrenoleukodystrophy - Pipeline Review, H2 2011\', provides an overview of the Adrenoleukodystrophy therapeutic pipeline. This report provides information on the therapeutic development for Adrenoleukodystrophy, complete with l |
|
|
| Generic drugs market is anticipated to grow at a CAGR of around 17% during FY 2011- 2013 driven by patent expiries, investment, and private sector participation etc.... |
|
|
| Increasing demand for newborn screening, high incidences of Alzheimer disease, breast cancer, etc will help genetic testing market to grow at a CAGR of around 26% during 2012-2015... |
|
|
| The obesity drug market is expected to be worth US$ 2.5 Billion by the end of 2014, growing at a CAGR of around 13% during 2011-2014..... |
|
|
| The UK is one of the largest economies in the world. The per capita income and spending has been also increasing for the last few years... |
|
|
| The generics market in the US has good growth potential in various therapy segments, which have attracted investments and market revenue in recent times. In this regard, our report provides rational a |
|
|
| Backed by patent expiration of blockbuster drugs and active ingredients such as anastrozole, telmisartan, etc., generics market is projected to grow at a CAGR of around 8% during 2009-2013...... |
|
Company Reports
US Office
India Office